Publications 2014

Patrizia Giannoni, Kévin Baranger, Sarah Girot, Stéphane Girard, Florence Gaven, et al.. Memory deficits of 5xFAD mice in the olfactory H maze test correlate with plaques development and are prevented by 5-HT4R agonist treatments.. AAIC, Jul 2014, Copenhague, Denmark. ⟨hal-02918560⟩
Stéphane D. Girard, Marlyse Jacquet, Kévin Baranger, Martine Migliorati, Guy Escoffier, et al.. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease. Hippocampus, 2014, 24 (7), pp.762--772. ⟨10.1002/hipo.22267⟩. ⟨hal-01718190⟩
Patrizia Giannoni, Florence Gaven, Kévin Baranger, Santiago Rivera, Philippe Marin, et al.. Activation chronique du récepteur de la sérotonine de type 4 : Effet préventif dans un model murin de la maladied’Alzheimer. (Conférencière invitée). Réunion francophone sur la maladie d'Alzheimer, Jun 2014, Montpellier, France. ⟨hal-02918585⟩
Nathalie A. Py, Amandine E. Bonnet, Anne Bernard, Yannick Marchalant, Eliane Charrat, et al.. Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Frontiers in Aging Neuroscience, 2014, 6, pp.247. ⟨10.3389/fnagi.2014.00247⟩. ⟨hal-01718189⟩
Kévin Baranger, Santiago Rivera, Fabian D. Liechti, Denis Grandgirard, Judit Bigas, et al.. Endogenous and synthetic MMP inhibitors in CNS physiopathology. Progress in brain research, 2014, 214, pp.313--351. ⟨10.1016/B978-0-444-63486-3.00014-1⟩. ⟨hal-01718187⟩
Jessica Thevenard, Laurie Verzeaux, Jerôme Devy, Nicolas Etique, Albin Jeanne, et al.. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. PLoS ONE, 2014, 9 (7), pp.e103839. ⟨10.1371/journal.pone.0103839⟩. ⟨hal-01718192⟩
Landel Véréna, Baranger Kévin, Virard Isabelle, Loriod Béatrice, Michel Khrestchatisky, et al.. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease. Molecular Neurodegeneration, 2014, 9, pp.33. ⟨10.1186/1750-1326-9-33⟩. ⟨inserm-01071449⟩